Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 27, 2014
Pharmacy Choice - News - Generic Drugs - November 27, 2014

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 46     Next >>     Go To Page:

11/27/14 - NHS Framework for the supply of Generic Pharmaceuticals Wave 9c. [TendersInfo (India)]
Contract notice: NHS Framework for the supply of Generic Pharmaceuticals Wave 9 c. Potential periods of call-offs under the framework agreement: 100% oral products: All regions 1.7. 2015 to 28.2. 2017 33% hospital only products: DLN/DNW 1.7. 2015 to 30.6. 2017 Housekeeping products: DLS/DNE 1.7. 2015 to 29.2. 2016 and DCE/DSW 1.7. 2015 to 31.10. 20
11/27/14 - Teva announces new chairman
Israeli pharma giant Teva yesterday elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost, who is due to step down at the end of the year. Frost had wanted to steer Teva towards specialty pharmaceuticals while other board members wanted the world's biggest generic drugmaker to focus on its core business. Peterburg, with Teva since 200
11/27/14 - United States : Omnicare and McKesson Expand Distribution Agreement [TendersInfo (India)]
Omnicare Inc. and McKesson Corporation announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. As part of the expanded agreement, McKesson will now also assume responsibility for the sourcing and distribution of generic pharmaceuticals for Omnicare as part of McKesso
11/26/14 - Global Biosimilars/Follow-on-Biologics Market 2013-2020 - Technology, Types, Applications, Services Analysis of the $35 Billion Market
Dublin- Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market- Research Report, 2013- 2020" report to their offering. Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, t
11/26/14 - Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development
Dublin- Research and Markets has announced the addition of the "Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development" report to their offering. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of bio
11/26/14 - Patent Issued for Microtablet-Based Pharmaceutical Preparation
By a News Reporter-Staff News Editor at Biotech Week A patent by the inventor Rohr, Wolfgang, filed on February 9, 2007, was published online on November 11, 2014, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8883205 is assigned to Biogenerics Pharma GmbH. The following quote was obtai
11/26/14 - Prof. Yitzhak Peterburg Elected Chairman of Teva's Board of Directors
Teva Pharmaceutical Industries Ltd. today announced that the Board of Directors has elected Professor Yitzhak Peterburg as Chairman, effective January 1, 2015. After an extensive international search, the Board determined that Yitzhak is best placed to provide the leadership and vision we need to strengthen Teva s position as a global player
11/26/14 - Rep. Cummings Introduces Bill to Require Drug Manufacturers to Pay Additional Rebate
Elijah E. Cummings, D- Md., has introduced legislation to "extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs." For more information about congressional legislation and services offered by Targeted News Service to tra
11/26/14 - Research and Markets: Global Biosimilars/Follow-on-Biologics Market 2013-2020 - Technology, Types, Applications, Services Analysis of the $35 Billion Market
Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market- Research Report, 2013- 2020" report to their offering. Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, the Europ
11/26/14 - Research and Markets: Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development
Research and Markets has announced the addition of the "Overview and Background of Biosimilars 2014: What They are and a Timeline of their Development" report to their offering. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around the development and approval of biosimilars
11/26/14 - Sen. Sander Introduces Bill to Apply Medicaid Additional Requirement to Generic Drug Manufacturers
by MERLY LAPIG Targeted News Service. For more information about congressional legislation and services offered by Targeted News Service to track issues, key words or members of Congress who introduce or co-sponsor legislation, please contact editor@targetednews.com or call 703/ 304-1897.. For more information about Targeted News Service products a
11/26/14 - The People's Pharmacy: Generic drug prices are skyrocketing [Gazette, The (CO)]
An article in the New England Journal of Medicine notes the price of the blood pressure medicine captopril increased more than 2,800 percent between November 2012 and November 2013, from 1.4 cents per pill to 39.9 cents per pill. Doxycycline was first marketed as Vibramycin in 1967. It has long been available as an inexpensive, broad- spectrum gene
11/26/14 - The People's Pharmacy: Generic drug prices are skyrocketing [The Gazette (Colorado Springs, Colo.)]
An article in the New England Journal of Medicine notes the price of the blood pressure medicine captopril increased more than 2,800 percent between November 2012 and November 2013, from 1.4 cents per pill to 39.9 cents per pill. Doxycycline was first marketed as Vibramycin in 1967. It has long been available as an inexpensive, broad- spectrum gene
11/25/14 - Beximco Pharma Becomes First Bangladeshi Company to Receive GMP Approval from Health Canada
Release date- 24112014- Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that it has received GMP approval from the Canadian regulatory authority, Health Canada. Beximco Pharma is the first Bangladeshi company to receive GMP accreditation from...
11/25/14 - Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.
Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii under which Breckenridge and Pii expect to develop and commercialize several new ANDA's. Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a.
11/25/14 - Cuba sells medicines and health technology to more than 50 countries
Havana, Nov 25.- Cuba sells medicines and health technologies to more than 50 countries, including vaccines, generic medications, equipment and diagnostic systems, the official daily Juventud Rebelde reported Tuesday. "About 30 new products from Cuba and a group of generics are being exported to Bolivarian Alliance for the Peoples of Our America m
11/25/14 - MALLINCKRODT PLC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated and combined financial statements and the accompanying notes included in this Annual Report on Form 10- K. The following discussion may contain forward-looking statements that reflect our plans, estimates an
11/25/14 - Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC
Mylan Inc. today confirmed that it and several subsidiaries have been sued by Baxter International, Inc., Baxter Healthcare Corporation and Baxter Healthcare S.A., in connection with the filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Esmolol HCl in Sodium Chloride Injection, 10 mg/ml and 20 mg/ml.
11/25/14 - Research and Markets: Global Oncology Biosimilars Market 2014-2018 with Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, Mylan & Sandoz Dominating
Research and Markets has announced the addition of the "Global Oncology Biosimilars Market 2014-2018" report to their offering. The Global Oncology Biosimilars market to grow at a CAGR of 29.87% over the period 2013-2018.. Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the.
11/25/14 - SUPERNUS PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits
On November 21, 2014, Supernus Pharmaceuticals, Inc. issued a press release announcing that it sued generic drug makers Zydus Pharmaceuticals Inc. and Cadila Healthcare Limited for infringement of three patents covering its antiepileptic drug Trokendi XR . On November 24, 2014, Supernus Pharmaceuticals, Inc. issued a press release announcing the.
11/25/14 - Synthon Initiates Treatment of First Patients in Phase I Trial of anti-HER2 ADC SYD985 based on its Proprietary Linker-Drug Platform
The trial will include breast cancer patients with low expression of HER2. NIJMEGEN, the Netherlands Synthon Biopharmaceuticals today announced that the first patients with metastatic solid tumors have commenced treatment with its investigational anti-HER2 antibody-drug conjugate, SYD985.. First patients for this trial are being enrolled in lea
11/25/14 - Taglich Brothers Initiates Coverage on Trxade Group, Inc.
Taglich Brothers, Inc. announces it initiated coverage of Trxade Group, Inc.. Trxade Group Inc., based in Lutz, Florida, operates an Internet-based exchange that promotes and enables trading among independent pharmacies and pharmaceutical suppliers. Proprietary software enables users of Trxade's network to compare prices of branded and generic drug
11/24/14 - Beximco Gets Good Manufacturing Practices Approval In Canada
LONDON- Beximco Pharmaceuticals Ltd said Monday that it has received good manufacturing practices approval from the Canadian regulatory authority, Health Canada. Beximco, a generic pharmaceutical product manufacturer, said it was the first Bangladeshi company to receive this accreditation from Health Canada. Shares in Beximco are untraded Monday,..
11/24/14 - CONSOLIDATION IN US HURTS INDIAN GENERIC FIRMS
The extensive consolidation of pharmaceutical supply chains in the US where wholesale and retail drug suppliers since 2012 have teamed up to procure generic medicines are starting to hurt revenues of Indian generics players. Most of the Indian pharma companies derive a majority of their foreign sales from the US market. In the US, drug distributors
11/24/14 - Dr. Reddy's Announces the Launch of Docetaxel Injection USP
Reddy s Laboratories announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE in the US market on November 21, 2014. Reddy s ANDA is approved by the United States Food& Drug Administration. The TAXOTERE brand and generic has U.S. sales of approximately $218
Articles(s): 1 - 25 of 46     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
HIV & AIDS Testing & Reporting Guidelines
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415